Evidence map›Paper›PMID 35715395›Full record

ArticleNature communications2022

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants.

Scotland E Farley, Jennifer E Kyle, Hans C Leier, Lisa M Bramer, Jules B Weinstein, Timothy A Bates, Joon-Yong Lee, Thomas O Metz, Carsten Schultz, Fikadu G Tafesse

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Measles virus reprograms CD4Frontiers in cell and developmental biology · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Scotland E FarleyDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA.
Jennifer E KyleBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, USA.ORCID http://orcid.org/0000-0002-9282-9005
Hans C LeierDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA.
Lisa M BramerBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, USA.ORCID http://orcid.org/0000-0002-8384-1926
Jules B WeinsteinDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-2983-3386
Timothy A BatesDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-2533-7668
Joon-Yong LeeBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, USA.ORCID http://orcid.org/0000-0002-5864-8518
Thomas O MetzBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, USA.ORCID http://orcid.org/0000-0001-6049-3968
Carsten SchultzDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, USA.
Fikadu G TafesseDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA. tafesse@ohsu.edu.ORCID http://orcid.org/0000-0002-8575-4164

Funding

Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Pacific Northwest Advanced Compound Identification CoreU2CES030170 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI RENSLOW, RYAN SCOTT · 2018 to 2021
$4.6M
Determining the role of sphingolipids in Mycobacterium tuberculosis infectionR01AI141549 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2020 to 2025
$2.4M
NHLBI NIH HHS T32 HL083808NIAID NIH HHS R01 AI141549NIEHS NIH HHS U2C ES030170
6 · The paper itself

Abstract

A comprehensive understanding of host dependency factors for SARS-CoV-2 remains elusive. Here, we map alterations in host lipids following SARS-CoV-2 infection using nontargeted lipidomics. We find that SARS-CoV-2 rewires host lipid metabolism, significantly altering hundreds of lipid species to effectively establish infection. We correlate these changes with viral protein activity by transfecting human cells with each viral protein and performing lipidomics. We find that lipid droplet plasticity is a key feature of infection and that viral propagation can be blocked by small-molecule glycerolipid biosynthesis inhibitors. We find that this inhibition was effective against the main variants of concern (alpha, beta, gamma, and delta), indicating that glycerolipid biosynthesis is a conserved host dependency factor that supports this evolving virus.

Indexed as

COVID-19SARS-CoV-2HumansLipidsViral ProteinsLipidsViral Proteins

Identifiers

PMID35715395
PMCPMC9203258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.